EternaTear was founded with the mission to revolutionize the treatment of dry eye by developing next-generation, over-the-counter artificial tear solutions. The company focuses on providing longer-lasting relief for individuals suffering from dry eye, a condition characterized by itching, burning, and pain due to the inability of the tear film and lids to protect the eye surface. EternaTear aims to address the diverse underlying causes of dry eye, which can lead to significant discomfort and potential corneal damage if untreated.
Notable figures affiliated with EternaTear include leading experts in ophthalmology and pharmaceutical development, although specific names are not provided. The company has garnered attention from key investors interested in innovative healthcare solutions. EternaTear's primary achievement lies in its development of a more effective artificial tear product that promises to enhance the quality of life for dry eye sufferers. Their impact is marked by the potential to set new standards in dry eye treatment within the over-the-counter market.
